White label ELPA - ClinicalTrials.eu

Study Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
- Non-small cell lung cancer metastatic
Investigated Drugs:
+2
Study of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma or Primary Mediastinal Large B-cell Lymphoma

Not recruiting

2 1 1 1
Investigated Drugs:
- Pembrolizumab
Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

Not recruiting

3 1 1
Investigated Drugs:
- Palbociclib
+5
Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Not recruiting

3 1 1
Investigated Diseases:
- Giant cell arteritis
Investigated Drugs:
- Secukinumab
- Prednisone
+11
Study on the Effectiveness and Safety of Atropine and DIMS Lenses for Myopia Control in Children

Not recruiting

3 1 1 1
Investigated Drugs:
- Atropine Sulfate
Study on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk

Not recruiting

3 1 1 1
Investigated Diseases:
- Metastatic renal cell carcinoma
Investigated Drugs:
Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Not recruiting

3 1 1 1
Investigated Drugs:
+7
Study on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

Not recruiting

2 1 1
Investigated Diseases:
- Crohn’s disease
Investigated Drugs:
- Bi 706321
- Ustekinumab
Study on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Not recruiting

3 1 1
Investigated Diseases:
- Thrombotic thrombocytopenic purpura
Investigated Drugs:
- Apadamtase Alfa
Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer

Not recruiting

3 1 1
Investigated Drugs:
- Tucatinib
- Trastuzumab Emtansine
+2

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies